ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2021

Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database".

Joerg Putzke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.